"The Global Bioinformatics Market Size was valued at USD 15.6 billion in 2024 and is projected to reach USD 17.3 billion in 2025. Worldwide sales of Bioinformatics are expected to grow at a significant CAGR of 12.3%, reaching USD 50.5 billion by the end of the forecast period in 2034."
Bioinformatics Market Overview
The bioinformatics market is undergoing rapid growth due to increasing integration of biology with information technology. It plays a critical role in managing and analyzing vast biological datasets generated from genomics, transcriptomics, proteomics, and metabolomics research. The rise of next-generation sequencing (NGS), personalized medicine, and drug discovery has accelerated demand for advanced bioinformatics tools. Applications range across healthcare, agriculture, environmental science, and forensic research. Cloud computing, artificial intelligence, and machine learning are revolutionizing how genomic data is stored, accessed, and interpreted. North America holds the dominant market share, while Asia-Pacific is poised for fastest growth due to rising biotech investments and digital infrastructure. Government funding for large-scale genome projects, increasing collaborations between tech firms and biopharmaceutical companies, and the expansion of clinical diagnostics further boost the market. However, challenges such as data privacy concerns, shortage of skilled professionals, and standardization issues remain key barriers.
In the coming years, the bioinformatics market is projected to grow steadily, supported by advancements in precision medicine, real-time disease tracking, and multi-omics research. The transition to cloud-native platforms and bioinformatics-as-a-service (BaaS) models is enhancing accessibility for academic and commercial end-users alike. Moreover, the development of unified platforms capable of integrating various types of omics data is transforming research efficiency and healthcare decision-making. Open-source frameworks and collaborative software development are becoming central to industry innovation. As healthcare systems globally adopt genomic data in clinical workflows, the demand for scalable, interoperable, and secure bioinformatics platforms is expected to rise. The market will also benefit from emerging applications in agriculture for crop optimization and pest resistance, in environmental science for microbial studies, and in food science for traceability and safety analysis.
Key insights
• The surge in next-generation sequencing (NGS) has led to a significant rise in biological data volumes, driving strong demand for scalable bioinformatics tools that support genome assembly, variant analysis, and annotation, especially across clinical and pharmaceutical applications.
• Bioinformatics is a cornerstone of personalized medicine, offering computational support for genomic profiling that informs patient-specific treatment decisions, biomarker identification, and therapy response predictions in oncology, cardiology, and neurology.
• Artificial intelligence and machine learning technologies are enhancing bioinformatics platforms by enabling deeper insights into complex biological data, improving drug target identification, and advancing early disease diagnostics through predictive modeling.
• Cloud-based bioinformatics platforms are gaining popularity due to their ability to handle vast datasets, support collaboration, reduce infrastructure costs, and offer real-time analysis—critical for both academic and commercial users with evolving data needs.
• Government funding for precision medicine and genomic research programs is fueling bioinformatics adoption globally, especially in North America, Europe, and rapidly growing markets like China and India, where national genome projects are underway.
• The agriculture sector is increasingly adopting bioinformatics for genomic-assisted breeding, pest resistance gene identification, and crop yield optimization, helping meet food security challenges while reducing dependency on chemical inputs.
• Bioinformatics tools are critical in pharmaceutical R&D, helping to shorten drug discovery timelines, improve target validation, and streamline clinical trials through integrative omics analysis and patient stratification methods.
• Educational and research institutions are increasingly investing in bioinformatics to support collaborative research projects, academic genomics studies, and open-access data sharing initiatives across global scientific communities.
• Partnerships between technology companies and biotech firms are driving innovation in proprietary bioinformatics software, customized for specific therapeutic areas like immunology, infectious diseases, and rare genetic disorders.
• The market still faces barriers such as inconsistent data standards, cybersecurity risks, and a shortage of skilled professionals, prompting a need for regulatory alignment and specialized training to support sustainable industry growth.
Major Players in the Bioinformatics Market
1. Thermo Fisher Scientific Inc.
2. Illumina Inc.
3. QIAGEN
4. Agilent Technologies
5. Bio-Rad Laboratories
6. Roche Sequencing
7. PerkinElmer Inc.
8. BGI Genomics
9. Eurofins Scientific
10. Waters Corporation
11. SOPHiA GENETICS
12. Partek Incorporated
13. DNASTAR
14. Biomax Informatics AG
15. PierianDx
Market Segmentation
By Product & Service:
- Data Analysis Software
- Database Management Services
- IT/Computing Services
By Application:
- Genomics
- Proteomics
- Transcriptomics
By End User:
- Academic Institutes
- Pharmaceutical Companies
- Research Centers
Recent Developments
-
April 2025 Signios Bio rebranded from MedGenome's research division, launching an advanced AI-powered, multi-omics bioinformatics platform designed to accelerate precision medicine and drug discovery with integrated genomic, proteomic, and spatial data capabilities.
-
April 2025 Novocraft and Basepair forged a strategic cloud-based partnership to offer advanced genomic pipelines on a pay-as-you-go model, granting researchers access to premium alignment and variant-calling tools without the need for local computing infrastructure.
-
May 2025 Pluto Bio secured $3.6 million in investment to expand its enterprise-grade AI-driven multi-omics analysis platform, aiming to scale adoption within global pharmaceutical R&D environments for collaborative, no-code computational biology workflows.
-
June 2025 A comprehensive bioinformatics deal-tracking report highlighted that more than 900 collaborations and licensing deals have been initiated since 2019, reflecting escalating strategic alliances between biotech, pharma, and bioinformatics technology providers.
-
May 2025 ZEISS partnered with Alpenglow Biosciences to co-develop a cutting-edge light-sheet microscope paired with a dedicated bioinformatics pipeline, improving volumetric data analysis for cellular and structural biology research.
Get Free Sample
At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
The Global Bioinformatics Market is estimated to generate USD xxx.x million in revenue in 2059
The Global Bioinformatics Market is expected to grow at a Compound Annual Growth Rate (CAGR) of x.xx% during the forecast period from 2024 to 2031.
By 2031, the Bioinformatics Market is estimated to account for USD xxx.x million
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
